Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ImmuCell Corporation - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ICCC
Nasdaq
3840
immucell.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ImmuCell Corporation
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
- Apr 13th, 2026 2:38 pm
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
- Apr 8th, 2026 2:05 pm
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
- Mar 18th, 2026 2:05 pm
ImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
- Mar 6th, 2026 6:02 pm
ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve
- Mar 6th, 2026 10:43 am
ImmuCell Q4 Earnings Call Highlights
- Mar 5th, 2026 7:07 pm
ImmuCell Corporation Q4 2025 Earnings Call Summary
- Mar 5th, 2026 6:30 am
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
- Mar 4th, 2026 2:05 pm
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
- Feb 18th, 2026 6:37 am
Niche Focus & Regulation Shape the Future of Healthcare Firms
- Jan 15th, 2026 9:24 am
Those who invested in ImmuCell (NASDAQ:ICCC) a year ago are up 25%
- Jan 12th, 2026 6:02 am
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
- Jan 8th, 2026 2:05 pm
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
- Jan 7th, 2026 6:10 am
Top Stock Reports for AbbVie, Coca-Cola & Chevron
- Dec 24th, 2025 11:10 am
ImmuCell Announces Strategic Focus on First DefenseĀ® After Receiving an FDA Incomplete Letter for Re-TainĀ®
- Dec 24th, 2025 11:05 am
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth
- Dec 4th, 2025 9:14 am
ImmuCell Corp (ICCC) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
- Nov 24th, 2025 6:02 pm
ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength
- Nov 20th, 2025 5:42 am
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
- Nov 13th, 2025 2:05 pm
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
- Nov 6th, 2025 2:05 pm
Scroll